Readiness: The state of the science (or the Lack Thereof)

Current HIV/AIDS Reports

Volumn 7, Issue 4, 2010, Pages 245-252

  Grimes, Richard M ^b   Grimes, Deanna E ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT HOUSTON   (United States)

^b NONE

Author keywords

Adherence; AIDS; Antiretroviral therapy; HIV; Readiness

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY;

FOLLOW UP; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PATIENT ATTITUDE; PATIENT COMPLIANCE; PATIENT DECISION MAKING; PRACTICE GUIDELINE; REVIEW; SYSTEMATIC REVIEW; THERAPY DELAY;

ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4 LYMPHOCYTE COUNT; CLINICAL PROTOCOLS; HEALTH BEHAVIOR; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HIV; HIV INFECTIONS; HUMANS; MEDICATION ADHERENCE; PATIENT ACCEPTANCE OF HEALTH CARE; PATIENT PARTICIPATION; PRACTICE GUIDELINES AS TOPIC; TREATMENT REFUSAL;

EID: 77958096285     PISSN: 15483568     EISSN: 15483576     Source Type: Journal    
DOI: 10.1007/s11904-010-0056-2     Document Type: Review

References (41)

1. BG Gazzard J Anderson A Babiker, et al. 2008 British HIV Association guidelines for the treatment of HIV-1-infected adults with antiretroviral therapy 2008 HIV Med 9 563 608 1:CAS:528:DC%2BD1cXht12hs7%2FK 10.1111/j.1468-1293.2008.00636.x 18826546
2. Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Department of Health and Human Services. December 1, 2009; 1-161. Available at http://www.aidsinfo.nih.gov/ContentFiles/AdultandAdolescentGL.pdf. Accessed May 10, 2010.
3. SM Hammer JJ Eron Jr P Reiss, et al. 2008 Antiretroviral treatment of adult HIV infection - 2008 recommendations of the International AIDS Society-USA Panel JAMA 300 555 570 1:CAS:528:DC%2BD1cXps1ylsbc%3D 10.1001/jama.300.5.555 18677028
4. Clumeck N, Dedes N, Pozniak A, Raffi F, and the EACS Executive Committee: Guidelines, clinical management and treatment of HIV infected adults in Europe. Available at http://www.europeanaidsclinicalsociety.org/guidelines.asp. Accessed May 10, 2010.
5. Catalan J, Collins P, Mash B, Freeman M: Psychotherapeutic interventions in antiretroviral therapy: for second level care. Available at http://whqlibdoc.who.int/publications/2005/9241593091-eng.pdf. Accessed May 10, 2010.
6. DR Bangsberg S Perry ED Charlebois, et al. 2001 Nonadherence to highly active antiretroviral therapy predicts progression to AIDS AIDS 15 1181 1183 1:STN:280:DC%2BD3MzltFKhug%3D%3D 10.1097/00002030-200106150-00015 11416722 (Pubitemid 32549871)
7. R Gross B Yip V Lo Re 3rd, et al. 2006 A simple, dynamic measure of antiretroviral therapy adherence predicts failure to maintain HIV-1 suppression J Infect Dis 194 1108 1114 10.1086/507680 16991085 (Pubitemid 44547650)
8. DL Paterson S Swindells J Mohr, et al. 2000 Adherence to protease inhibitor therapy and outcomes in patients with HIV infection Ann Intern Med 133 21 30 1:STN:280:DC%2BD3czit1altA%3D%3D 10877736
9. O Nordqvist B Sodergard MP Tully, et al. 2006 Assessing and achieving readiness to initiate HIV medication Patient Educ Couns 62 21 30 10.1016/j.pec.2005.09.014 16766244 This is an excellent review of the early studies and essays on readiness. It was a starting point for our review. (Pubitemid 43832071)
10. J Prochaska C DiClemente 1983 Stages and process of self-change of smoking: Toward an integrative model of change J Consult Clin Psychol 51 390 395 1:STN:280:DyaL3s3jvFaksw%3D%3D 10.1037/0022-006X.51.3.390 6863699
11. GR Highstein C Willey LM Mundy 2006 Development of stage of readiness and decisional balance instruments: tools to enhance clinical decision-making for adherence to antiretroviral therapy AIDS Behav 10 563 573 10.1007/s10461-005- 9043-9 16552624 (Pubitemid 44285077)
12. RC Rathbun KC Farmer SM Lockhart JR Stephens 2007 Validity of a state of change instrument in assessing medication in indigent patients with HIV infection Ann Pharmacother 41920 208 214
13. C Willey C Redding J Stafford, et al. 2000 Stages of change for adherence with medication regimens for chronic disease: development and validation of a measure Clin Ther 22 858 871 1:STN:280:DC%2BD3M%2FksFWitg%3D%3D 10.1016/S0149-2918(00)80058-2 10945512 (Pubitemid 30625918)
14. L Gardner G Marks LR Metsch, et al. 2007 Psychological and Behavioral Correlates of Entering Care for HIV Infection: The Antiretroviral Treatment Access Study (ARTAS) AIDS Patient Care STDS 21 418 425 10.1089/apc.2006.0115 17594251 This is the largest study that examined readiness to enter care. It was based on the stages of change model and provides some useful insights into why individuals delay seeking care. (Pubitemid 46988407)
15. M Enriquez A-L Cheng DS McKinsey J Stanford 2009 Development and efficacy of an intervention to enhance readiness for adherence among adults who had previously failed HIV treatment AIDS Patient Care STDS 23 177 184 10.1089/apc.2008.0170 19866535 This an intriguing study in that it used an intervention on 28 patients who had failed at least four previous regimens. The intervention was either six or 12 sessions to help patients become "ready" to resume HAART (readiness was not defined or measured). Fourteen of these patients had undetectable viral loads at 3 months, and 11 had undetectable viral loads at 12 months.
16. L Balfour GA Tasca J Kowal, et al. 2007 Development and validation of the HIV medication readiness scale Assessment 14 408 416 10.1177/1073191107304295 17986658 This study tested a 10-item HIV readiness scale that was found to be predictive of adherence after 1 month of treatment. The short follow-up and the use of two measures of self-report to define adherence raise caution flags. However, it is an approach that should be replicated in patients who will be followed for a longer period of time.
17. ME Fowler 1998 Recognizing the phenomenon of readiness: concept analysis and case study J Assoc Nurs AIDS Care 9 72 76 1:STN:280:DyaK1c3ltFehtQ%3D%3D 10.1016/S1055-3290(98)80021-6
18. M Enriquez PA Gore MC O'Connor DS McKinsey 2004 Assessment of readiness for adherence by HIV-positive males who had previously failed treatment J Assoc Nurs AIDS Care 15 42 49 10.1177/1055329003256209 (Pubitemid 38552972)
19. B Sodergard M Halvarsson S Lindback, et al. 2006 Differences in adherence and motivation to HIV therapy-two independent assessments in 1998 and 2002 Pharm World Sci 28 248 256 10.1007/s11096-006-9036-4 17066240 (Pubitemid 44673753)
20. B Sodergard S Hofer M Halvarsson, et al. 2007 A structural equation modeling approach to the concepts of adherence and readiness in antiretroviral treatment Patient Educ Counsel 67 108 116 10.1016/j.pec.2007.02.010 (Pubitemid 46880124)
21. B Tessema B Fantahun A Andargachew, et al. 2010 Magnitude and determinants of nonadherence and nonreadiness to highly active antiretroviral therapy among people living with HIV/AIDS in Northwest Ethiopia: A cross sectional study AIDS Res Ther 7 1 8 10.1186/1742-6405-7-2
22. JD Fleury 1991 Empowering potential: a theory of wellness motivation Nurs Res 40 286 291 1:STN:280:DyaK3MznsFyksQ%3D%3D 10.1097/00006199-199109000-00009 1896327
23. HT Gebrekristos K Mlisana KA Karim 2005 Patient readiness to start highly active antiretroviral Therapy for HIV BMJ 331 772 774 10.1136/bmj.331.7519.772 16195299
24. L Weiss T French R Finkelstein, et al. 2003 HIV-related knowledge and adherence to HAART AIDS Care 15 673 679 1:STN:280:DC%2BD3svitVWitA%3D%3D 10.1080/09540120310001595159 12959818 (Pubitemid 37193856)
25. L Balfour J Kowal GA Tasca, et al. 2007 Development and psychometric validation of the HIV Treatment Knowledge Scale AIDS Care 19 1141 1148 1:STN:280:DC%2BD2sjis12gtg%3D%3D 10.1080/09540120701352241 18058398 (Pubitemid 350223195)
26. V Cooper D Buick R Horner, et al. 2002 Perceptions of HAART among gay men who declined a treatment offer: preliminary results from an interview-based study AIDS Care 14 319 328 1:STN:280:DC%2BD38zgtVyrsA%3D%3D 10.1080/ 09540120220123694 12042077 (Pubitemid 34620836)
27. G Gellaitry V Cooper C Davis, et al. 2005 Patients' perception of information about HAART: Impact on treatment decisions AIDS Care 17 367 376 1:STN:280:DC%2BD2M7pvFWqtQ%3D%3D 10.1080/09540120512331314367 15832885 (Pubitemid 40188919)
28. R Gold DT Ridge 2001 "I will start treatment when I think the time is right": HIV-positive gay men talk about their decision not to access antiretroviral therapy AIDS Care 13 693 708 1:STN:280:DC%2BD3MnnsVKrug%3D%3D 10.1080/09540120120076869 11720640 (Pubitemid 34014236)
29. JS Fehr D Nicca P Sendi, et al. 2005 Starting or changing therapy-a prospective study exploring antiretroviral decision-making Infection 33 249 256 1:STN:280:DC%2BD2MvisVGnug%3D%3D 10.1007/s15010-005-4141-1 16091895 (Pubitemid 41152185)
30. TT Morgenstern DE Grimes RM Grimes 2002 Pilot study: assessment of readiness to initiate antiretroviral therapy HIV Clin Trials 3 168 172 10.1310/T6Y6-BRCW-AR7A-WVA3 11976996
31. H Kremer G Ironson N Schneiderman M HautZinger 2006 To take or not to take: Decision-making about antiretroviral treatment in people living with HIV/AIDS AIDS Patient Care STDs 20 335 349 10.1089/apc.2006.20.335 16706708 (Pubitemid 43800962)
32. RM Grimes DE Grimes 2009 Patient readiness to adhere to HAART J Int Assoc Phys AIDS Care 8 364 366 10.1177/1545109709351240 This study demonstrated that asking patients if they think they are ready has no predictive value at all. It did not matter whether patients were naïve to HAART or restarting after a greater than 6 month "drug holiday." It suggests that future studies along this line are likely to be futile.
33. L Balfour J Kowal S Silverman, et al. 2006 A randomized controlled psycho-education intervention trial: Improving psychological readiness for successful HIV medication adherence and reducing depression before initiating HAART AIDS Car 18 830 838 1:STN:280:DC%2BD28rksFeltg%3D%3D 10.1080/ 09540120500466820 (Pubitemid 44395531)
34. V Alfonso N Bermbach J Geller JS Montaner 2006 Individual variability in barriers affecting people's decision to take HAART: A qualitative study identifying barriers to being on HAART AIDS Patient Care STDs 20 848 857 10.1089/apc.2006.20.848 17192150 (Pubitemid 46106072)
35. M Sidat C Fairley J Grierson 2007 Experiences and perceptions of patients with 100% adherence to highly active antiretroviral therapy: a qualitative study AIDS Patient Care STDs 21 509 520 10.1089/apc.2006.0201 17651032 (Pubitemid 47221646)
36. G Wagner M Iguchi S Schneider, et al. 2002 Placebo practice trials: a tool to assess and improve adherence readiness HIV Clin Trials 3 475 481 10.1310/XGXU-FUDK-A9QT-MPTF 12501131 In this study, 20 patients took placebos for a 2-week trial and were monitored by electronic devices until they showed that they could adhere at >90%. This took up to five trials for some patients. Of the 15 patients who achieved "readiness," 87% achieved >90% adherence.
37. G Wagner 2003 Placebo practice trials: the best predictor of adherence readiness for HAART among drug users? HIV Clin Trials 4 269 281 10.1310/YVTR-T8EV-3TQ6-QAJC 12916013 This was a follow-up trial using the methods from reference 36. A total of 201 patients, most with a history of substance abuse, were enrolled and 181 completed at least one trial. Eighty-three patients started HAART and only 33 achieved >90% adherence during a 2-week follow-up period. (Pubitemid 36974717)
38. M Enriquez NR Lackey MC O'Connor DS McKinsey 2004 Successful adherence after multiple HIV treatment failures J Adv Nurs 45 438 446 10.1046/j.1365-2648. 2003.02928.x 14756838
39. CE Golin H Liu RD Hays, et al. 2002 A prospective study of predictors of adherence to combination antiretroviral medication J Gen Intern Med 17 756 765 10.1046/j.1525-1497.2002.11214.x 12390551 (Pubitemid 35286241)
40. WL Holzemer S Bakken CJ Portillo, et al. 2006 Testing a nurse-tailored HIV medication adherence intervention Nurs Res 55 189 197 10.1097/00006199- 200605000-00005 16708043 (Pubitemid 44503666)
41. J Wise D Operario 2008 Use of electronic reminder devices to improve adherence to antiretroviral therapy: A systematic review AIDS Patient Care STDs 22 495 504 10.1089/apc.2007.0180 18462071